Research programme: selective serotonin 2A/2C receptor agonists - Pharmacia
Alternative Names: PNU-57378ELatest Information Update: 12 May 2006
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Serotonin 5-HT2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 12 May 2006 No development reported - Preclinical for Anxiety disorders in USA (unspecified route)
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer